Transplantation Maintains Key Role in Myeloma Treatment, but Questions Remain
Navneet Majhail, MD, MS reviews findings presented at ASH and shares his thoughts about ongoing research.
What is the role of autologous stem cell transplantation in multiple myeloma given the availability of potent new chemotherapeutic agents now used in combination regimens, what is optimal timing for transplantation and which patients might benefit?
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
In this “top takeaway” feature, Navneet Majhail, MD, MS, Director of Cleveland Clinic’s Blood & Marrow Transplant Program, and Ajai Chari, MD, Icahn School of Medicine at Mount Sinai, review findings presented at ASH, share their thoughts and discuss ongoing research.
Photo Credit ©Russell Lee